Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysis

S Giacchetti, Pierre-Antoine Dugué, P F Innominato, Gunnar Bjarnason, C Focan, C Garufi, S Tumolo, B Coudert, S Iacobelli, R Smaaland, M Tampellini, R Adam, T Moreau, F Lévi, ARTBC International Chronotherapy Group

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

117 Citationer (Scopus)

Abstract

Molecular circadian clocks can modify cancer chemotherapy effects, with a possible moderation according to sex differences. We investigated whether sex determine the optimal delivery schedule of chemotherapy for metastatic colorectal cancer.
OriginalsprogEngelsk
TidsskriftAnnals of oncology : official journal of the European Society for Medical Oncology / ESMO
Vol/bind23
Udgave nummer12
Sider (fra-til)3110-6
Antal sider7
DOI
StatusUdgivet - dec. 2012
Udgivet eksterntJa

Citationsformater